BioSpace News Archive

Enteris poised to capitalize on multiple value building opportunities involving Peptelligence® and ProPerma™ platforms

Genuity Science, a U.S.-headquartered data, analytics and insights organization, today announces an agreement with one of the world’s leading medical research institutions, Emory University.

Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today announced the formation of its Scientific Advisory Board (SAB).

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced final immunogenicity and interim safety results of the ongoing clinical trial evaluating HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted] in patients undergoing hemodialysis.

PharmaEssentia Corporation (TPEx: 6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced the initiation of SURPASS ET, a Phase 3 pivotal clinical trial of its investigational ropeginterferon alfa-2b (P1101),

Seagen Inc. (Nasdaq: SGEN) today announced that it will report its fourth quarter and full year 2020 financial results on Thursday, February 11, 2021 after the close of U.S. financial markets. Following the announcement, Company management will host a conference call and webcast discussion of the results and provide a general corporate update. Access to the event can be obtained as follows: Thursday, February 11, 2021

Monte Rosa Therapeutics to Present at 39 th Annual J.P. Morgan Healthcare Conference

Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners, announced today the acquisition of Clinical Logistics Inc. (“CLI”), a Virtual Central Specimen Management CRO based in Halifax, Canada . The acquisition enables Caprion-HistoGeneX to broaden its specimen logist

Vericel Corporation, a leader in advanced therapies for the sports medicine and severe burn care markets, announced that UnitedHealthcare has expanded its medical policy for MACI® to include coverage for patients with symptomatic full-thickness cartilage defects in the patella and multiple cartilage defects in the knee.

ThermoGenesis Holdings, Inc. (Nasdaq: THMO) a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Jeff Cauble , Chief Financial Officer, will present a company overview at the H.C. Wainwright BIOCONNECT 2021 Conference. The presentation will be available